Femasys Inc — 四半期キャッシュフロー (NASDAQ:FEMY)

Financials

総資産 12.45 M13.28 M13.78 M16.29 M20.72 M 負債合計 10.14 M11.28 M12.27 M11.73 M14.85 M 純資産合計 2.3 M2 M1.51 M4.56 M5.87 M 負債および純資産合計 12.45 M13.28 M13.78 M16.29 M20.72 M 有利子負債合計 5.41 M7.16 M7.35 M1.42 M3.18 M 純負債 1.95 M3.34 M4.13 M-3.14 M-6.09 M

ニュース

Femasys begins enrollment in pivotal trial for FemBloc device

Lake Street、Femasys株にカバレッジ開始、買い推奨レーティング

Lake Street initiates Femasys stock coverage with buy rating

Femasys receives CPT code approval for infertility treatment

Femasys社、スイスでの新たな販売提携により株価上昇

Femasys expands European presence with Swiss distribution deal

Femasys社、最低入札価格規則を満たすためNasdaqから180日間の延長を獲得

Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule

Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment

Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232

Pharmacyte Biotech CEO Silverman buys $80k in shares

Femasys receives FDA clearance for FemVue Controlled diagnostic device